Shrinkage priors for isotonic probability vectors and binary data modeling, with applications to dose–response modeling.
- Published in:
- Pharmaceutical Statistics, 2024, v. 23, n. 4, p. 540, doi. 10.1002/pst.2372
- By:
- Publication type:
- Article
Works matching IS 15391604 AND DT 2024 AND VI 23 AND IP 4
Results: 11
1
2
Sample size calculation for comparing two ROC curves.
- Published in:
- Pharmaceutical Statistics, 2024, v. 23, n. 4, p. 557, doi. 10.1002/pst.2371
- By:
- Publication type:
- Article
3
A generalized Bayesian optimal interval design for dose optimization in immunotherapy.
- Published in:
- Pharmaceutical Statistics, 2024, v. 23, n. 4, p. 480, doi. 10.1002/pst.2369
- By:
- Publication type:
- Article
4
Predicting subgroup treatment effects for a new study: Motivations, results and learnings from running a data challenge in a pharmaceutical corporation.
- Published in:
- Pharmaceutical Statistics, 2024, v. 23, n. 4, p. 495, doi. 10.1002/pst.2368
- By:
- Publication type:
- Article
5
On sample size calculation in drug interaction trials.
- Published in:
- Pharmaceutical Statistics, 2024, v. 23, n. 4, p. 530, doi. 10.1002/pst.2367
- By:
- Publication type:
- Article
6
Assessing the performance of group‐based trajectory modeling method to discover different patterns of medication adherence.
- Published in:
- Pharmaceutical Statistics, 2024, v. 23, n. 4, p. 511, doi. 10.1002/pst.2365
- By:
- Publication type:
- Article
7
On the relative conservativeness of Bayesian logistic regression method in oncology dose‐finding studies.
- Published in:
- Pharmaceutical Statistics, 2024, v. 23, n. 4, p. 585, doi. 10.1002/pst.2364
- By:
- Publication type:
- Article
8
A case study: Assessing the efficacy of the revised dosage regimen via prediction model for recurrent event rate using biomarker data.
- Published in:
- Pharmaceutical Statistics, 2024, v. 23, n. 4, p. 570, doi. 10.1002/pst.2362
- By:
- Publication type:
- Article
9
The flaw of averages: Bayes factors as posterior means of the likelihood ratio.
- Published in:
- Pharmaceutical Statistics, 2024, v. 23, n. 4, p. 466, doi. 10.1002/pst.2355
- By:
- Publication type:
- Article
10
Transporting randomized trial results to estimate counterfactual survival functions in target populations.
- Published in:
- Pharmaceutical Statistics, 2024, v. 23, n. 4, p. 442, doi. 10.1002/pst.2354
- By:
- Publication type:
- Article
11
Issue Information.
- Published in:
- Pharmaceutical Statistics, 2024, v. 23, n. 4, p. 439, doi. 10.1002/pst.2310
- Publication type:
- Article